RARC vs LRC in A Multicenter Cohort Study

Not yet recruiting

• Conditions: Bladder Cancer

• Registration Number: NCT05885204
• Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Brief Summary

A multicenter, retrospective research was conducted. Patients who underwent robot-assisted radical cystectomy and laparoscopic radical cystectomy in 10 large medical centers in China were enrolled, comparing the oncologic outcomes of the patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-05
• Study First Submitted: 2023-05-23
• Study First Submitted QC: 2023-05-23
• Last Update Submitted: 2023-05-23
• Study Start: 2023-06-01
• Study First Posted: 2023-06-01
• Last Update Posted: 2023-06-01
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 3815

Inclusion Criteria

• >18 years old; Clinical stage Ta-T4a/N0-3/M0

Exclusion Criteria

• Severe cardiovascular disease; History of previous major abdominopelvic surgery; Patients with distant metastases; Medical history of malignancy in other organs.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Survival	Five years	Time from surgery until death from any cause.
Cancer-specific Survival	Five years	Time from date of surgery to death from bladder cancer.
Recurrence-free Survival	Five years	Time from surgery to tumor recurrence which identified either pathologically or radiographically.